Align Technology Is Maintained at Outperform by Mizuho
Wells Fargo Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $255
Align Technology Earnings: What To Look For From ALGN
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $275
9 Health Care Stocks Whale Activity In Today's Session
Align Tech (ALGN) Gets a Buy From Stifel Nicolaus
Align Technology Price Target Cut to $170.00/Share From $290.00 by HSBC
HSBC Downgrades Align Technology to Hold From Buy, Adjusts Price Target to $170 From $290
UBS Maintains Align Technology(ALGN.US) With Hold Rating, Cuts Target Price to $215
Earnings Preview: ALGN to Report Financial Results Post-market on April 30
Align Technology Is Maintained at Neutral by UBS
Align Technology Analyst Ratings
UBS Adjusts Price Target on Align Technology to $215 From $240, Maintains Neutral Rating
Align Technology Announces Commercial Availability of Invisalign System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction for the United States and Canada at AAO
Is Align Technology, Inc. (NASDAQ:ALGN) Trading At A 45% Discount?
Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus
Short Bets Against S&P 500 Healthcare Stock Rises in March; MRNA Stays Top Shorted
Piper Sandler Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $235
Morgan Stanley Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $249
Dentsply Sirona Downgraded at Morgan Stanley on Macro/ Demand Headwinds